LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 52.27 | 770.25 | 5750 | 7058 | 0.8146 | 0.8757 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 54.49 | 770.25 | 7171 | 7555 | 0.9491 | 0.9685 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 54.49 | 770.25 | 5926 | 7555 | 0.7843 | 0.8578 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 56.71 | 770.25 | 7575 | 8001 | 0.9467 | 0.9678 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 56.71 | 770.25 | 6329 | 8001 | 0.7910 | 0.8658 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 58.94 | 770.25 | 8069 | 8444 | 0.9556 | 0.9739 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 58.94 | 770.25 | 6701 | 8444 | 0.7936 | 0.8705 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 61.16 | 770.25 | 8530 | 8892 | 0.9593 | 0.9766 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 61.16 | 770.25 | 7082 | 8892 | 0.7965 | 0.8751 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 63.39 | 770.25 | 8831 | 9326 | 0.9469 | 0.9699 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 63.39 | 770.25 | 7432 | 9326 | 0.7969 | 0.8777 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 65.61 | 770.25 | 9199 | 9736 | 0.9448 | 0.9692 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 65.61 | 770.25 | 7712 | 9736 | 0.7921 | 0.8766 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 67.83 | 770.25 | 9597 | 10078 | 0.9522 | 0.9738 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 67.83 | 770.25 | 7977 | 10078 | 0.7915 | 0.8778 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 70.05 | 770.25 | 9901 | 10413 | 0.9508 | 0.9733 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 70.05 | 770.25 | 8106 | 10413 | 0.7784 | 0.8710 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 72.27 | 770.25 | 10167 | 10730 | 0.9475 | 0.9718 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 72.27 | 770.25 | 8249 | 10730 | 0.7687 | 0.8663 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 74.50 | 770.25 | 10381 | 10991 | 0.9445 | 0.9704 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 74.50 | 770.25 | 8407 | 10991 | 0.7649 | 0.8650 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 76.75 | 770.25 | 10539 | 11262 | 0.9357 | 0.9660 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 76.75 | 770.25 | 8532 | 11262 | 0.7575 | 0.8615 | MN20160304_L02 | L06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 78.98 | 770.25 | 10694 | 11518 | 0.9284 | 0.9623 | MN20160304_L02 | C12 |
MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 78.98 | 770.25 | 8596 | 11518 | 0.7463 | 0.8555 | MN20160304_L02 | L06 |